Skip to content

Anaesthetic and Pediatric Living Related Liver Transplantation

The Effect of Sevoflurane or Propofol on Brain Injury and Neurocognitive in Pediatric Living Related Liver Transplantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03024840
Enrollment
60
Registered
2017-01-19
Start date
2016-12-31
Completion date
2017-12-31
Last updated
2017-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Liver Transplantation

Keywords

Propofol, Neurocognitive Disorders, Liver transplantation, Pediatrics, Brain Injuries

Brief summary

To study the effect of different anaesthetic methods on pediatric neurocognitive development and cerebral injury during pediatric living related liver transplantation .

Detailed description

Since the 1960 s, with the successful development of liver transplantation, it has become an important method for the treatment of patients with end-stage liver disease.Biliary atresia1 is the most frequent causes of pediatric end-stage liver disease,.The morbidity of congenital biliary atresia is 1/8000-18, 0002 ,which influence the patients' overall growth and development situation. The rising of living donor liver transplantation has provide children with the chance of a timely treatment since the 1980 s, It is no doubt that pediatric liver transplantation is facing with many complications, including the most importance of neurocognitive development .Now the researches of neurological complications is less .According to statistics, the incidence of neurological complications after pediatric liver transplantation was 8% - 46% . So it is necessary to research the neurological complications and brain protection strategy .Previous studies have studied that some anaesthetic have uncertain affect on the development of children.

Interventions

DRUGSevoflurane

Sevoflurane: 1%\ 2%

DRUGPropofol

Propofol: 9-15 mg/kg/h

Sponsors

Tianjin First Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
4 Months to 12 Months
Healthy volunteers
No

Inclusion criteria

* Children with end-stage liver disease Children with biliary atresia

Exclusion criteria

* pre-existing cerebral disease second liver transplantation

Design outcomes

Primary

MeasureTime frame
Evidence of cerebral injury including S-100 β protein, neurospecific enolase confirmed by electrochemiluminescencebefore skin incision, 0.5 hour after anhepatic,1 hour of neohepatic stage,the end of surgery,24 hours after operation
Evidences of inflammatory factor such as interleukin-6,interleukin-10,et al confirmed by electrochemiluminescencebefore skin incision, 0.5 hour after anhepatic,1 hour of neohepatic stage,the end of surgery,24 hours after operation

Secondary

MeasureTime frame
Evaluation of neurocognitive disorder using Bayley Scales of Infant Development1 day before surgery, 7days,14 days and 21days of post-operation
Evaluation of delirium using Pediatric Anesthesia Emergence DeliriumWithin 1 days after extubation
hemodynamics indexbefore skin incision, 0.5 hour after anhepatic,1 hour of neohepatic stage,the end of surgery,24 hours after operation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026